Ignite Creation Date:
2025-12-24 @ 7:37 PM
Ignite Modification Date:
2026-01-25 @ 12:37 AM
Study NCT ID:
NCT03149003
Status:
COMPLETED
Last Update Posted:
2023-11-15
First Post:
2017-05-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy
Sponsor:
Sumitomo Pharma America, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-12-08
Start Date Type:
ACTUAL
Primary Completion Date:
2021-08-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-08-30
Completion Date Type:
ACTUAL
First Submit Date:
2017-05-09
First Submit QC Date:
None
Study First Post Date:
2017-05-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-11-08
Results First Submit QC Date:
None
Results First Post Date:
2023-01-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-13
Last Update Post Date:
2023-11-15
Last Update Post Date Type:
ACTUAL